DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma

Phase 2

Completed

Conditions: Malignant Peritoneal Mesothelioma

Interventions: Drug: erlotinib hydrochloride

First Posted Date: 2012-05-07

Last Posted Date: 2018-10-16

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT01592383

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Phase 4

Terminated

Conditions: Hepatitis C

Interventions: Drug: Peginterferon alfa-2a
Drug: Ribavirin
Drug: telaprevir

First Posted Date: 2012-05-04

Last Posted Date: 2016-06-15

Lead Sponsor: University of Chicago

Target Recruit Count: 3

Registration Number: NCT01592006

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

Phase 2

Completed

Conditions: Castration-resistant Prostate Cancer
Stage IV Prostate Cancer

Interventions: Drug: abiraterone acetate

First Posted Date: 2012-03-05

Last Posted Date: 2019-07-05

Lead Sponsor: University of Chicago

Target Recruit Count: 72

Registration Number: NCT01543776

Locations: 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Ingalls Memorial Hospital, Harvey, Illinois, United States
🇺🇸
Illinois Cancer Care, Peoria, Illinois, United States

and more 3 locations

Evaluating the Patient-Ventilator Synchrony During Mechanical Ventilation in Patients With Acute Lung Injury

Completed

Conditions: Mechanically Ventilated ICU Patients

First Posted Date: 2012-03-01

Last Posted Date: 2014-12-03

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT01541514

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Susceptibility to Pathological Gambling

Not Applicable

Completed

Conditions: Pathological Gambling

Interventions: Behavioral: Mindfulness
Behavioral: Cognition

First Posted Date: 2012-02-08

Last Posted Date: 2024-08-01

Lead Sponsor: University of Chicago

Target Recruit Count: 588

Registration Number: NCT01528982

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Stem Cell Transplantation for Patients With Multiple Myeloma

Phase 1

Active, not recruiting

Conditions: Myeloma

Interventions: Drug: G-CSF
Drug: Plerixafor
Procedure: Apheresis
Drug: Melphalan
Procedure: Stem cell re-infusion
Device: CliniMACS CD25 microbeads and cell sorter
Drug: Basiliximab

First Posted Date: 2012-02-03

Last Posted Date: 2025-02-05

Lead Sponsor: University of Chicago

Target Recruit Count: 15

Registration Number: NCT01526096

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

Phase 1

Completed

Conditions: Recurrent Breast Cancer
Male Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IV Breast Cancer
Stage IIIC Breast Cancer

Interventions: Drug: placebo
Drug: mifepristone
Drug: nab-paclitaxel

First Posted Date: 2011-12-15

Last Posted Date: 2018-09-12

Lead Sponsor: University of Chicago

Target Recruit Count: 9

Registration Number: NCT01493310

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
NorthShore University Health System, Evanston, Illinois, United States

Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome

Completed

Conditions: Allergic Rhinitis

Interventions: Other: Swab of vestibule and middle meatus of nose

First Posted Date: 2011-10-28

Last Posted Date: 2014-03-27

Lead Sponsor: University of Chicago

Target Recruit Count: 40

Registration Number: NCT01461200

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Teaching Use of Respiratory Inhalers (TURI)

Not Applicable

Completed

Conditions: COPD
Asthma

Interventions: Other: Teach-to-Goal Education
Other: Brief Intervention

First Posted Date: 2011-10-20

Last Posted Date: 2019-06-18

Lead Sponsor: University of Chicago

Target Recruit Count: 50

Registration Number: NCT01456494

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

The Efficacy of Claritin in Healthy Subjects

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Claritin

First Posted Date: 2011-10-14

Last Posted Date: 2018-03-13

Lead Sponsor: University of Chicago

Target Recruit Count: 340

Registration Number: NCT01451996

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy